Evidence map›Paper›PMID 41890275›Full record

ArticleFrontiers in insect science2026

Evaluating the new product Norroa™ against

Devan Rawn, Cody Prouty, Asmita Gautam, Matthew Jamison, Win Talton, Katie Youngs, Ken Narva, Brian Manley, Cameron Jack

Abstract read
In one paragraph

Article in Frontiers in insect science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Norroa™ as a dsRNA biopesticide forFrontiers in insect science · 2026
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Devan RawnEntomology and Nematology Department, University of Florida, Gainesville, FL, United States.
Cody ProutyEntomology and Nematology Department, University of Florida, Gainesville, FL, United States.
Asmita GautamEntomology and Nematology Department, University of Florida, Gainesville, FL, United States.
Matthew JamisonGreenLight Biosciences, Research Triangle Park, Durham, NC, United States.
Win TaltonGreenLight Biosciences, Research Triangle Park, Durham, NC, United States.
Katie YoungsGreenLight Biosciences, Research Triangle Park, Durham, NC, United States.
Ken NarvaGreenLight Biosciences, Research Triangle Park, Durham, NC, United States.
Brian ManleyGreenLight Biosciences, Research Triangle Park, Durham, NC, United States.
Cameron JackEntomology and Nematology Department, University of Florida, Gainesville, FL, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Globally, beekeepers must manage the invasive mite pest Methods: Field studies were conducted to test the effectiveness of Norroa™ during a nectar-flow season and a nectar-dearth season in Florida. In each field trial, 36 colonies were established for testing. Mite infestation rates were measured throughout the trials and mites were assessed for gene knockdown by determining RNA concentrations from the target gene. A final trial was conducted uncapping honey bee pupae and examining mite reproduction. Results: During the nectar dearth, mite numbers started higher (4.56 mites/100 bees) and increased more in control colonies compared with the treated colonies, but differences were not significant. During the nectar-flow, Norroa™ maintained Discussion: Research related to biological methods of control are currently under-studied relative to chemical treatments. These trials demonstrate the promise of a new tool for beekeepers to control

Indexed as

Apis melliferahoney beeNorroaRNAivadescana

Identifiers

PMID41890275
PMCPMC13013518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.